appScorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
News & Opinions
Hindustan Bio Sciences reports standalone net profit of Rs 0.05 crore in the December 2022 quarter
7 months ago•Business Standard
Hindustan Bio Sciences reports standalone net loss of Rs 0.07 crore in the September 2022 quarter
10 months ago•Business Standard
Hindustan Bio Sciences reports standalone net loss of Rs 0.39 crore in the March 2022 quarter
1 year ago•Business Standard
Hindustan Bio Sciences reports standalone nil net profit/loss in the December 2021 quarter
1 year ago•Business Standard
Hindustan Bio Sciences reports standalone net loss of Rs 0.06 crore in the September 2021 quarter
1 year ago•Business Standard
Hindustan Bio Sciences reports standalone net loss of Rs 0.08 crore in the June 2021 quarter
2 years ago•Business Standard
Hindustan Bio Sciences reports standalone net loss of Rs 0.11 crore in the December 2020 quarter
2 years ago•Business Standard